Most breast changes caused by GLP-1 use and weight loss are usually benign however you should seek assessment if you notice: A new lump or area of thickening One breast changing more than the other Skin dimpling, redness or puckering Nipple inversion or discharge Persistent pain in an area Even when changes are likely to be weight-related, imaging (ultrasound, mammography or MRI in selected cases) can provide clarity and peace of mind and also enables a new post weight-loss baseline to be established
40,41 Whereas a modified ITT analysis inclusive of postdiscontinuation weights showed smaller reductions in weight, differences between tirzepatide and semaglutide were similar
These platforms primarily offered compounded GLP-1 products, which are facing increasing FDA regulatory scrutiny in 2026
Rosacea is a chronic skin disorder primarily affecting the face, often characterized by facial redness, visible blood vessels, swelling, and occasionally small, red, pus-filled bumps
We subsequently performed quantitative measurement of ONSD using standardized amplitude modulation (A-scan) echography with tissue sensitivity settings, placing the 8 MHz A-scan probe on the temporal eye equator in primary gaze position, as previously described by others [24, 25]
